Attention Startups: Apply to Bayer G4A Partnerships 2020!
Don't delay! Applications close on June 30, 2020
The new edition of Bayer G4A Partnerships is now open for applications. Since 2013 Bayer has been collaborating with startups to improve the experience of health. This year they are looking for companies in the areas of Cardiometabolic and Renal Diseases, Oncology, Women’s Health, and Pharmacovigilance.
“This year hasn’t been an easy one for a lot of companies, and G4A understands that. The world has seen some of the highest casualties within the most vulnerable populations within healthcare and a seismic shift which will pressure many healthcare players to redefine how they approach and sustain our healthcare systems. Instead of 20+ challenges like last year, this year we have refined our focus areas and are looking for partners in 9 very specific challenges’’. – Sophie Park, Chief Strategist, G4A Partnerships
G4A’s program offers two tracks for companies to partner with Bayer. Their Growth Track is designed for early-stage companies (Seed-Series A) and their Advance Track is for mature companies with a product or solution already in the market with traction.
‘’In the age of self-care and digital health management, successful products will result from the combination of a deep understanding of medical conditions, the current frictions and inefficiencies of the healthcare systems, as well as the behavioral and environmental factors that surround peoples’ realities. Digital and data driven solutions are an essential backbone to develop customer-focused products and services to help patients to improve their health at every stage of their lives’’.
As emerging and existing health challenges continue to affect the most vulnerable populations, G4A’s goal is to provide the access and tools to help people take control of their health and empower them to engage and change their lifestyle habits.
“Now more than ever before, our healthcare systems need to endorse integrated approaches to health and care which addresses patients’ needs and consider the complexity of multi-morbid patients.’’ – Javier Garcia, VP, Integrated Care Ventures
Partners benefit from Bayer’s global presence and business acumen to grow their healthcare business while G4A drives towards changing the experience of health through collaboration.
Visit G4A website to find out more about this year’s challenges.
Don't Delay: Applications close June 30th, 11:59pm Central European Time.
Meet our Premier Partners
Digital Health Today would not be possible without our valuable partners.